ADVERTISEMENT

US States

No Sale For Supplement Direct Sellers’ Ad Claims In Industry Self-Regulation Group’s Reviews

Urban Retreat didn’t cooperate with Direct Selling Self-Regulatory Council’s review or “indicate any intent to comply with” recommendations to discontinue claims for its Balance Capsules. LoveBiome responded sufficiently to merit a DSSRC recommendation to pull three health claims.

C&D Pulls Curtain Down On Gummy Vitamin Gambit With Sale To Piping Rock Health

Decision on vitafusion and L’il Critters business planned by end of year, but Piping Rock Health provided incentive for C&D to opt for divestiture.

Two Strikes And Firms Selling 7-OH Supplements Will Be Out Of Options To Avoid US Enforcement

Enforcements at facilities in Missouri operated by Shaman Botanicals and Relax Relief Rejuvenate Trading were preceded by administrative detention orders, FDA’s first use of the authority since its reorganization in October 2024.

In Challenge To Age-Restricted Sales, CRN Argues Court ‘Diluted Constitutional Protections’

CRN’s attorneys ask Second Circuit for en banc review of a three-judge panel’s denial of its appeal of 2024 decision in district court rejecting motion for preliminary injunction against enforcement of New York state law age-restricting sales of weight loss and muscle building supplements.

Industry’s Battle Against Age-Restricting Supplement Sales Spreads To Michigan

Lawmakers in IL, MA and NJ as well as MI consider proposals as firms marketing weight loss and bodybuilding supplements in New York already are subject to first-ever state law limiting sales of products to consumers 18 and older.

Appeals Court Clips CRN’s Constitutional Argument Against Age-Restricting Supplement Sales

Three-judge Second Circuit panel rejects CRN’s argument that New York General Business Law Section 391-oo, effective since April 2024 as first in US to prohibit sales of certain supplements to consumers under 18, violates First Amendment rights of supplement marketers.

US Limit On All THC In Hemp Included In Stopgap FY 2026 Spending Bill Could Choke Industry

Provision supported by Sen. Mitch McConnell, R-KY, along with House Appropriations Committee chair Andy Harris, R-MD, tightens definition of lawful hemp to exclude any THC derivative from cannabis at more than 0.3% concentration by dry weight and specifically exclude synthetics.

Senate’s Proposed Agreement To End US Shutdown Would Cut FDA Non-User Fee Funding

But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.

California Firm Too Busy To Defend Ad Claims For NAD+ Supplement It Previously Marketed

Virgin Scent didn’t respond to NAD attorneys’ “repeated outreach attempts” asking for evidence supporting ad claims for Artnaturals NAD+ challenged by another NAD+ supplement marketer, Reus Research.

US Consumer Health People Moves: HRG’s Wendland Retires, WIN Star For AHPA’s Johnson

Dave Wendland retires after 34 years at HRG; AHPA science chief Holly Johnson earns WIN Guiding Star; Strategy, people leads for Vitamin Shoppe; CDMO Kenox appoints R&D, manufacturing VP; and contract manufacturer Radienz adds customer chief.

Kenvue’s Tylenol Litigation Overhang Doesn’t Dim ‘Generational Opportunity’ For Kimberly-Clark

“Incredible rigor, thoughtfulness and discipline” went into Kleenex tissues, Huggies disposable diapers, and Kotex tampons marketer Kimberly-Clark’s $48.7bn offer for Kenvue, the former J&J consumer health products business on its own for two years.

Texas Waves ‘MAHA’ Flag With Complaint Alleging Autism Link To Prenatal Acetaminophen Exposure

In addition to Kenvue, complaint names as defendant J&J, which for decades marketed Tylenol oral analgesics before spinning Kenvue out in 2023. State asks court to order firms to pay $10,000 for each violation of state Deceptive Trade Practices-Consumer Protection Act.